Literature DB >> 2342904

Patient experiences with research in a tertiary care setting.

E Larson1, D B McGuire.   

Abstract

Data from a number of studies indicate that patients' understanding and recall of information presented during the informed consent process are poor. The purpose of this survey was to determine patients' attitudes about, desired knowledge of, and involvement in clinical research in a tertiary medical care setting. A self-report questionnaire was completed by 277 patients on the oncology, obstetrics/gynecology, medicine, neurosciences, surgery, and ophthalmology services of a large tertiary care facility. While most respondents had generally positive attitudes about research, relatively few were aware that human subjects approval processes existed or that nurses conducted research. Areas of additional knowledge needed included specific information about purposes of research and risks and benefits. Individuals with higher levels of education appeared more willing to participate in clinical research even when personal benefit was minimal.

Entities:  

Mesh:

Year:  1990        PMID: 2342904

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  4 in total

1.  Neonatal research: the parental perspective.

Authors:  B J Stenson; J-C Becher; N McIntosh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 2.  Impact of cancer on everyday life: a systematic appraisal of the research evidence.

Authors:  Ikumi Okamoto; David Wright; Claire Foster
Journal:  Health Expect       Date:  2011-02-18       Impact factor: 3.377

3.  Patients' perceptions of research in emergency settings: a study of survivors of sudden cardiac death.

Authors:  Neal W Dickert; Nancy E Kass
Journal:  Soc Sci Med       Date:  2008-11-10       Impact factor: 4.634

4.  Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial.

Authors:  Krysia Canvin; Ann Jacoby
Journal:  Trials       Date:  2006-12-12       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.